# BridgeBio Pharma, Inc.: Form 8-K, filed Jun 22, 2021

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2021-06-22
- Accepted by EDGAR: Jun 22, 2021, 16:31 ET
- Period: 2021-06-17
- Accession: 0001193125-21-196269
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312521196269/d134534d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312521196269/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312521196269/d134534d8k.htm

Filed Jun 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-196269. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
